The yield of chromosomal microarray analysis among pregnancies terminated due to fetal malformations

Yael Pasternak*, Yair Daykan, Tamar Tenne, Eyal Reinstein, Netanella Miller, Gil Shechter-Maor, Idit Maya, Tal Biron-Shental, Rivka Sukenik Halevy

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Background: Chromosomal microarray analysis (CMA) is preferred for genetic work-up when fetal malformations are detected prenatally. Objectives: To assess the detection rate of CMA after pregnancy termination due to abnormal ultrasound findings. Methods: CMA was successfully performed in 71 pregnancies using fetal DNA (mainly from skin) or placenta. Data regarding clinical background, pregnancy work-up, and CMA were analyzed. Results: Findings were abnormal in 17 cases (23.9%), of which 13 were detectable by karyotype. The incremental yield of CMA was 4/71 (5.6%); 1/32 (3.1%) for cases with an isolated anomaly and 3/39 (7.7%) for cases with nonisolated anomalies. Conclusions: CMA yield from terminated pregnancies was 23.9%. Although most chromosomal abnormalities are detectable by karyotype, CMA does not require viable dividing cells; hence, it is more practical for work-up after termination. In most cases, the diagnosis was followed by consultation regarding the risk of recurrence and recommendations for testing in subsequent pregnancies.

Original languageEnglish
Pages (from-to)336-340
Number of pages5
JournalJournal of Maternal-Fetal and Neonatal Medicine
Volume35
Issue number2
DOIs
StatePublished - 2022

Keywords

  • Abnormal ultrasound findings
  • chromosomal microarray analysis
  • copy number variations
  • genetic work-up
  • termination of pregnancy

Fingerprint

Dive into the research topics of 'The yield of chromosomal microarray analysis among pregnancies terminated due to fetal malformations'. Together they form a unique fingerprint.

Cite this